Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eligard vs Lupron/Zoladex in advanced prostate cancer
NCT00220194Phase 4Completed
- Sponsor
- San Bernardino Urological Associates Medical Group
- Start
- Apr 2003
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of leuprolide in prostate cancer (PCa), sponsored by San Bernardino Urological Associates Medical Group. Started Apr 2003; status: completed.
02
Drugs
leuprolide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00220194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00220194.